Related Experiment Video
Updated: Jun 23, 2025
A Zebrafish Embryo Model for In Vivo Visualization and Intravital Analysis of Biomaterial-associated Staphylococcus aureus Infection
Published on: January 7, 2019
The zebrafish embryo model: unveiling its potential for investigating phage therapy against methicillin-resistant
Lucile Plumet1, Chloé Magnan2, Nour Ahmad-Mansour1
1VBIC, INSERM U1047, University of Montpellier, Montpellier, France.
Abstract:
Staphylococcus aureus is a pathogenic bacterium responsible for a broad spectrum of infections, including cutaneous, respiratory, osteoarticular, and systemic infections. It poses a significant clinical challenge due to its ability to develop antibiotic resistance. This resistance limits therapeutic options, increases the risk of severe complications, and underscores the urgent need for new strategies to address this threat, including the investigation of treatments complementary to antibiotics. The evaluation of novel antimicrobial agents often employs animal models, with the zebrafish embryo model being particularly interesting for studying host-pathogen interactions, establishing itself as a crucial tool in this field. For the first time, this study presents a zebrafish embryo model for the in vivo assessment of bacteriophage efficacy against S. aureus infection. A localized infection was induced by microinjecting either methicillin-resistant S. aureus (MRSA) or methicillin-susceptible S. aureus (MSSA). Subsequent treatments involved administering either bacteriophage, vancomycin (the reference antibiotic for MRSA), or a combination of both via the same route to explore potential synergistic effects. Our findings indicate that the bacteriophage was as effective as vancomycin in enhancing survival rates, whether used alone or in combination. Moreover, bacteriophage treatment appears to be even more effective in reducing the bacterial load in S. aureus-infected embryos post-treatment than the antibiotic. Our study validates the use of the zebrafish embryo model and highlights its potential as a valuable tool in assessing bacteriophage efficacy treatments in vivo.
Insights
Bacteriophages show promise as an alternative to antibiotics for treating Staphylococcus aureus infections. This study validates the zebrafish embryo model for assessing bacteriophage efficacy in vivo, finding phages as effective as vancomycin in improving survival rates.
Area of Science:
- Microbiology and Infectious Diseases
- Bacteriophage Therapy
- Zebrafish Embryo Model
Background:
- Staphylococcus aureus infections present a significant clinical challenge due to rising antibiotic resistance.
- Novel therapeutic strategies, including bacteriophage therapy, are urgently needed to combat resistant bacterial strains.
- The zebrafish embryo model offers a valuable platform for studying host-pathogen interactions and evaluating antimicrobial efficacy in vivo.
Purpose of the Study:
- To establish and validate a zebrafish embryo model for assessing bacteriophage efficacy against Staphylococcus aureus infections.
- To compare the efficacy of bacteriophage treatment with vancomycin, a standard antibiotic, in a zebrafish embryo model.
- To investigate potential synergistic effects between bacteriophages and vancomycin.
Main Methods:
- Localized Staphylococcus aureus (MRSA and MSSA) infection was induced in zebrafish embryos via microinjection.
- Treatment groups received bacteriophage, vancomycin, or a combination of both.
- Survival rates and bacterial load were assessed post-treatment to evaluate therapeutic efficacy.
Main Results:
- Bacteriophage treatment alone or in combination with vancomycin significantly enhanced survival rates in infected zebrafish embryos.
- The bacteriophage demonstrated comparable efficacy to vancomycin in improving survival.
- Bacteriophage treatment resulted in a greater reduction in bacterial load compared to vancomycin treatment.
Conclusions:
- The zebrafish embryo model is a validated and effective tool for in vivo assessment of bacteriophage efficacy against Staphylococcus aureus.
- Bacteriophages represent a promising therapeutic alternative or adjunct to conventional antibiotics for treating S. aureus infections.
- Further research into bacteriophage therapy is warranted, leveraging the capabilities of the zebrafish embryo model.
More Related Videos
11:20Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
10:19Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery
Published on: June 26, 2014